Composition

Active ingredients:10 ml of solution contains 5 mg naphazoline hydrochloride, 5 mg chlorpheniramine maleate.

Auxiliary substances:anhydrous disodium hydrophosphate, sodium dihydrophosphate monohydrate, cetrimide, disodium edetate, sodium chloride, water for injection.

 

Description

It is a clear, colorless, odorless solution.

 

Pharmacotherapeutic group

Antihistamine, decongestant.

 

ATC code:R01АВ02.

 

pharmacological properties

Nazolid is a combined  preparation with antihistamine and decongestant effects. Naphazoline hydrochloride constricts nasal mucosal arterioles by stimulating vascular alpha-adrenoceptors. This effect is fast and long-lasting. Naphazoline hydrochloride  provides conditions for cleaning the passage and entrance parts of the nasopharyngeal pockets during the application of drains. Chlorpheniramine maleate contained in the Nazolid preparation weakens rhinorrhea by having an anticholinergic effect, and blocks H1-receptors in allergic rhinitis and

prevents sinusitis.

 

Instructions for use

- Allergic rhinitis of various origins

- Accompanied by acute cold, sinusitis, common cold and inflammation of mucous membranes

symptomatic treatment of upper respiratory tract diseases

- During inflammation of the middle ear and Eustachian tube

 

Contraindications

Hypersensitivity to any component of the drug, severe hypertension, ischemic heart disease, angle-closure glaucoma.

 

Special instructions and precautions

Like other nasal decongestants, high doses and long-term use may cause nasal congestion.

 

Interaction with other drugs

Like other drugs containing naphazoline, it can enhance the effect of MAO-inhibitors on arterial pressure.

 

Use during pregnancy and lactation

Like other drugs containing naphazoline, it is used during pregnancy and lactation only under the supervision of a doctor.

 

Method of use and dosage

1-2 drops are instilled in the nose 4 times a day.

Nazolid can be prescribed to children over 6 years old and elderly patients.

 

Side effects

Nazolid is safe and well tolerated by patients at recommended doses. However

as with other naphazoline-containing drops, transient local irritation may occur

can

 

Overdose

Not recorded.

 

Release form

10 ml, in a plastic vial.

1 vial is packed in a cardboard box with a leaflet.

 

Store condition

It should be stored at a temperature not higher than 300C and out of the reach of children.

 

Shelf life

3 years

Do not use after the expiration date.

 

Condition of release from pharmacy

It is released on the basis of a prescription.

 

Producer

PHARCO PHARMACEUTICALS

Kilo 31 Alexandria-Cairo Desert Road, Alexandria Egypt